116th CONGRESS 2d Session |
To establish grant programs to improve the health of border area residents and for all hazards preparedness in the border area including bioterrorism, infectious disease, and noncommunicable emerging threats, and for other purposes.
March 3, 2020
Ms. Torres Small of New Mexico (for herself, Mrs. Kirkpatrick, Mr. Grijalva, Mr. Gonzalez of Texas, Mr. Vela, Ms. Jackson Lee, Ms. Escobar, Ms. Haaland, Mrs. Davis of California, and Mr. Vargas) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To establish grant programs to improve the health of border area residents and for all hazards preparedness in the border area including bioterrorism, infectious disease, and noncommunicable emerging threats, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
This Act may be cited as the “Border Health Security Act of 2020”.
Congress makes the following findings:
(1) The United States-Mexico border is an interdependent and dynamic region of approximately 15,000,000 residents and millions of border crossings each year, with significant and unique public health challenges.
(2) These challenges include low rates of health insurance coverage, poor access to health care services, lack of education or access to information, poverty, and high rates of dangerous diseases, such as tuberculosis and West Nile virus, as well as other noncommunicable diseases such as cardiovascular disease, asthma, diabetes, and obesity.
(3) As the 2020 dengue outbreak in Mexico and many parts of Latin America illustrates, diseases do not respect international boundaries, and a strong public health effort at and along the borders is crucial to not only protect and improve the health of Americans but also to help secure the country against threats to biosecurity and other emerging threats.
(4) For 20 years, the United States-Mexico Border Health Commission has served as a crucial binational institution to address these unique and truly cross-border health issues.
(5) In 2016, 66 percent of Canadians lived within 100 miles of the United States border. The 2003 epidemic of severe acute respiratory syndrome caused more than 250 illnesses in the Greater Toronto Area, just 80 miles from New York.
(6) The recent coronavirus outbreak has highlighted the need for continued coordination of resources, effective communication, and information sharing between countries to address emerging public health crises.
SEC. 3. United States-Mexico Border Health Commission Act amendments.
The United States-Mexico Border Health Commission Act (22 U.S.C. 290n et seq.) is amended—
(A) in paragraph (1), by striking “; and” and inserting “;”;
(B) in paragraph (2), by striking the period and inserting a semicolon; and
(C) by adding at the end the following:
“(3) to cooperate with the Canada-United States Pan Border Public Health Preparedness Council (referred to in this Act as the ‘Council’), as appropriate; and
“(4) to serve as an independent and objective body to both recommend and implement initiatives that solve border health issues.”;
(A) in subsection (b), by striking “should be the leader” and inserting “shall be the Chair”; and
(B) by adding at the end the following:
“(d) Providing advice and recommendations.—Members of the Commission and the Council may at any time provide advice or recommendations to the Secretary, Congress, or any Member of Congress concerning issues that are considered by the Commission or Council. Such advice or recommendations may be provided regardless of whether a request for such is made and regardless of whether the member or individual is authorized to provide such advice or recommendations by the Commission or Council or any other Federal official.”;
(3) by redesignating section 8 as section 12;
(4) by striking section 7 and inserting the following:
“SEC. 7. Border health grants.
“(a) Eligible entity defined.—In this section, the term ‘eligible entity’ means a State, public institution of higher education, local government, Indian Tribe, Tribal organization, urban Indian organization, nonprofit health organization, trauma center, critical access hospital or other hospital that serves rural or other vulnerable communities and populations, faith-based entity, or community health center receiving assistance under section 330 of the Public Health Service Act (42 U.S.C. 254b), that is located in the United States-Mexico border area or the United States-Canada border area.
“(b) Authorization.—From amounts appropriated under section 11, the Secretary, in consultation with members of the Commission and Council and in coordination with the Office of Global Affairs, shall award grants to eligible entities to address priorities and recommendations outlined by the strategic plan and operational work plan of the Commission and the Council, as authorized under section 9, to improve the health of United States-Mexico border area and United States-Canada border area residents.
“(c) Application.—An eligible entity that desires a grant under subsection (b) shall submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require.
“(d) Use of funds.—An eligible entity that receives a grant under subsection (b) shall use the grant funds for any of the following:
“(1) Programs relating to any one or more of the following:
“(A) Maternal and child health.
“(B) Primary care and preventative health.
“(C) Infectious disease testing, monitoring, and surveillance.
“(D) Public health and public health infrastructure.
“(E) Health promotion, health literacy, and health education.
“(F) Oral health.
“(G) Behavioral and mental health.
“(H) Substance abuse prevention and harm reduction.
“(I) Health conditions that have a high prevalence in the United States-Mexico border area or United States-Canada border area.
“(J) Medical and health services research.
“(K) Workforce training and development.
“(L) Community health workers and promotoras.
“(M) Health care infrastructure problems in the United States-Mexico border area or United States-Canada border area (including planning and construction grants).
“(N) Health disparities in the United States-Mexico border area or United States-Canada border area.
“(O) Environmental health.
“(P) Bioterrorism and zoonosis.
“(Q) Outreach and enrollment services with respect to Federal programs (including programs authorized under titles XIX and XXI of the Social Security Act (42 U.S.C. 1396 et seq.; 42 U.S.C. 1397aa et seq.)).
“(R) Trauma care.
“(S) Health research with an emphasis on infectious disease, such as measles, and pressing issues related to noncommunicable diseases.
“(T) Epidemiology and health research.
“(U) Cross-border health surveillance coordinated with Mexican Health Authorities or Canadian Health Authorities.
“(V) Chronic diseases, such as diabetes and obesity, particularly childhood obesity.
“(W) Community-based participatory research on border health issues.
“(X) Domestic violence and violence prevention.
“(Y) Cross-border public health preparedness.
“(2) Other programs as the Secretary determines appropriate.
“(e) Supplement, not supplant.—Amounts provided to an eligible entity awarded a grant under subsection (b) shall be used to supplement and not supplant other funds available to the eligible entity to carry out the activities described in subsection (d).
“SEC. 8. Grants for Early Warning Infectious Disease Surveillance in the border area.
“(a) Eligible entity defined.—In this section, the term ‘eligible entity’ means a State, local government, Indian Tribe, Tribal organization, urban Indian organization, trauma center, regional trauma center coordinating entity, or public health entity.
“(b) Authorization.—From funds appropriated under section 11, the Secretary shall award grants for Early Warning Infectious Disease Surveillance to eligible entities for infectious disease surveillance activities in the United States-Mexico border area or United States-Canada border area.
“(c) Application.—An eligible entity that desires a grant under this section shall submit an application to the Secretary at such time, in such manner, and containing such information as the Secretary may require.
“(d) Uses of funds.—An eligible entity that receives a grant under subsection (b) shall use the grant funds, in coordination with State and local all hazards programs, to—
“(1) develop and implement infectious disease surveillance plans and networks and public health emergency and readiness assessments and preparedness plans, and purchase items necessary for such plans;
“(2) coordinate infectious disease surveillance planning and interjurisdictional risk assessments in the region with appropriate United States-based agencies and organizations and appropriate authorities in Mexico or Canada;
“(3) improve infrastructure, including surge capacity, syndromic surveillance, and isolation and decontamination capacity, and policy preparedness, including for mutual assistance and for the sharing of information and resources;
“(4) improve laboratory capacity, in order to maintain and enhance capability and capacity to detect potential infectious disease, whether naturally occurring or the result of terrorism;
“(5) create and maintain a health alert network, including risk communication and information dissemination that is culturally competent and takes into account the needs of at-risk populations, including individuals with disabilities;
“(6) educate and train clinicians, epidemiologists, laboratories, and emergency management personnel;
“(7) implement electronic data and infrastructure inventory systems to coordinate the triage, transportation, and treatment of multicasualty incident victims;
“(8) provide infectious disease testing in the United States-Mexico border area or United States-Canada border area; and
“(9) carry out such other activities identified by the Secretary, members of the Commission, members of the Council, State or local public health authorities, representatives of border health offices, or authorities at the United States-Mexico or United States-Canada borders.
“SEC. 9. Plans, reports, audits, and by-laws.
“(1) IN GENERAL.—Not later than 2 years after the date of enactment of this section, and every 5 years thereafter, the Commission (including the participation of members representing both the United States and Mexican sections) and the Council (including the participation of members representing both the United States and Canada) shall each prepare a binational strategic plan to guide the operations of the Commission and the Council and submit such plan to the Secretary and Congress.
“(2) REQUIREMENTS.—The binational strategic plan under paragraph (1) shall include—
“(A) health-related priority areas determined most important by the full membership of the Commission or Council, as applicable;
“(B) recommendations for goals, objectives, strategies, and actions designed to address such priority areas; and
“(C) a proposed evaluation framework with output and outcome indicators appropriate to gauge progress toward meeting the objectives and priorities of the Commission or Council, as applicable.
“(b) Work plan.—Not later than January 1, 2023, and every 2 years thereafter, the Commission and the Council shall develop and approve an operational work plan and budget based on the strategic plan under subsection (a).
“(c) GAO review.—Not later than January 1, 2024, and every 2 years thereafter, the Comptroller General of the United States shall conduct an evaluation of the activities conducted by the Commission and the Council based on the operational work plans described in subsection (b) for the previous year and the output and outcome indicators included in the strategic plan described in subsection (a). The evaluation shall include a request for written evaluations from members of the Commission and the Council about barriers and facilitators to executing successfully the work plans of the Commission and the Council.
“(d) Biannual reporting.—The Commission and Council shall each issue a biannual report to the Secretary that provides independent policy recommendations related to border health issues. Not later than 3 months following receipt of each such biannual report, the Secretary shall provide to Congress the report and any studies or other materials produced independently by the Commission and Council.
“(e) Audits.—The Secretary shall annually prepare an audited financial report to account for all appropriated assets expended by the Commission and Council to address both the strategic and operational work plans for the year involved.
“(f) By-Laws.—Not later than 6 months after the date of enactment of this section, the Commission and Council shall develop and approve by-laws to provide fully for compliance with the requirements of this section.
“(g) Transmittal to congress.—The Commission and Council shall submit copies of the operational work plan and by-laws to Congress. The Comptroller General of the United States shall submit a copy of each evaluation completed under subsection (c) to Congress.
“(a) In general.—To the extent practicable and appropriate, plans, systems, and activities to be funded (or supported) under this Act for all hazard preparedness, and general border health, including with respect to infectious disease, shall be coordinated with Federal, State, and local authorities in Mexico, Canada, and the United States.
“(b) Coordination of health services and surveillance.—The Secretary, acting through the Assistant Secretary for Preparedness and Response, when appropriate, may coordinate with the Secretary of Homeland Security in establishing a health alert system that—
“(1) alerts clinicians and public health officials of emerging disease clusters and syndromes along the United States-Mexico border area and United States-Canada border area; and
“(2) warns of health threats, extreme weather conditions, disasters of mass scale, bioterrorism, and other emerging threats along the United States-Mexico border area and United States-Canada border area.
“SEC. 11. Authorization of appropriations.
“There is authorized to be appropriated to carry out this Act $10,500,000 for fiscal year 2021 and each succeeding year, subject to the availability of appropriations for such purpose, of which $7,000,000 shall be made available to fund operationally feasible functions, activities, and grants with respect to the United States-Mexico border and the border health activities under cooperative agreements with the border health offices of the States of California, Arizona, New Mexico, and Texas, and $3,500,000 shall be allocated for the administration of United States activities under this Act on the United States-Canada border and the border health authorities, acting through the Canada-United States Pan-Border Public Health Preparedness Council.”; and
(5) in section 12 (as so redesignated)—
(A) by redesignating paragraphs (3) and (4) as paragraphs (4) and (6), respectively;
(B) by inserting after paragraph (2), the following:
“(3) INDIANS; INDIAN TRIBE; TRIBAL ORGANIZATION; URBAN INDIAN ORGANIZATION.—The terms ‘Indian’, ‘Indian Tribe’, ‘Tribal organization’, and ‘urban Indian organization’ have the meanings given such terms in section 4 of the Indian Health Care Improvement Act (25 U.S.C. 1603).”; and
(C) by inserting after paragraph (4), as so redesignated, the following:
“(5) UNITED STATES-CANADA BORDER AREA.—The term ‘United States-Canada border area’ means the area located in the United States and Canada within 100 kilometers of the border between the United States and Canada.”.